1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Global Market Study on Pharmaceutical Excipients: Increased Drug Demand in Emerging Asia Pacific Market to Fuel Demand Multi-Functional Excipients

This Persistence Market Research (PMR) report examines the ‘Global Pharmaceutical Excipients Market’ for the period 2015-2021. The primary objective of the report is to offer updates and information related to market opportunities in the global pharmaceutical excipients market.

This Persistence Market Research (PMR) report examines the global pharmaceutical excipients market for the period 2015-2021. The primary objective of the report is to offer insights into the developments in the pharmaceutical excipients market that are significantly transforming global businesses and enterprises. Rising demand for reduced medicine dosage through consumption of sustained-release oral formulations is expected to bolster the growth of the pharmaceutical excipients market over the next five years. In addition, increasing demand for biologic drugs for their instantaneous effect and greater drug efficacies in developed Western European economies is expected to drive the growth of the pharmaceutical excipients thus aiding formulation of parenteral applications during the forecast period. Primary excipient demand emerges from developed pharmaceutical markets such as Europe and North America, as these companies in these regions possess highly developed and technically advanced drug manufacturing infrastructure.

The pharmaceutical excipients market report begins with an overview of the pharmaceutical excipients process and analysis about why excipients are needed in the manufacturing of drugs. This section includes identifying the key functions of excipients and the respective considerations in each segment for appropriate sizing of the market. The following section underlines factors influencing the growth of the pharmaceutical excipients market currently, along with details of the key trends, drivers, restraints, opportunities, and an analysis of impacts expected to be created by each of the drivers and restraints over the forecast period. Impact analysis of the key regional growth drivers and restraints have been assessed based on a weighted average factor model along with key region-specific trends. This has been included in the pharmaceutical excipients market report to better equip clients with information and hidden insights. At the end of the report, PMR has provided an exclusive section on key strategic considerations for a new entrant planning to enter the pharmaceutical excipient in near term. The section highlights key requirements, which should be used to assess the quality of excipients produced, to better capture higher market share and emerge sustainably profitable over the long term.

The global pharmaceutical excipients market is analysed by chemistry type (i.e. source of origin), segmented into plant-based, animal-based, mineral-based and synthetically derived excipients. Based on functionality, the market has been segmented into binders (binders, coatings and fillers), glidents, diluents, disintegrants and others (solvents, co-solvents, anti-microbial agents, lubricants, colorants, emulsifiers, and humectants). By application type, the market has been segmented into oral, topical, parenteral formulations and others, which include suppositories, intra-muscular, ophthalmic preparations in terms of value, over the forecast period. A detailed analysis of every segment in terms of market size, Y-o-Y growth rate, absolute $ opportunity, market attractive index, and BPS analysis has been provided along with appropriate rationale.

The next section of the report highlights the growth trends witnessed in the pharmaceutical excipients market, by region. It provides a market outlook for 2015-2021 and sets the forecast within the context of the pharmaceutical excipients market. The study discusses key regional trends contributing to the growth of the pharmaceutical excipients market worldwide, as well as analyses the extent to which the corresponding drivers are influencing this market in each region currently. Key regions assessed in this report include North America, Latin America, Europe, Asia-Pacific, and the MEA.

Analysis by chemistry type, application type, functionalities and regions helps in evaluating the present scenario and growth prospects of the pharmaceutical excipients market for the period 2015 - 2021. We have considered 2014 as the base year and provided data for the forecast period.

To ascertain the pharmaceutical excipients market size, we have also considered key quality assessment parameters that should be considered while judging the quality and grading of excipients. The forecast presented here assesses the total revenue generated, by value, across the pharmaceutical excipients market. In order to offer an accurate forecast, we started by sizing the current market, which forms the basis of how the pharmaceutical excipients market is expected to develop in the future. Given the characteristics of the market, we triangulated the outcome of the three different types of analysis, based on the supply side, downstream industry demand, and the economic envelope.

In addition, it is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR but also analyse based on key parameters, such as Year-on-Year (Y-o-Y) growth rates, to understand the predictability of the market and to identify the right opportunities in the pharmaceutical excipients market.

The pharmaceutical excipients segments have been analysed in terms of the Basis Point Share (BPS) to understand individual segment’s relative contributions to market growth. This detailed level of information is important for identification of various key trends in the pharmaceutical excipients market.

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective, in the pharmaceutical excipients market.

To understand key growth areas of pharmaceutical excipients in the near future, Persistence Market Research developed the pharmaceutical excipients market’s ‘Attractiveness Index’, which has been represented by for all four categories, chemistry type, application type, functionalities and regions. The resulting index is expected to help providers identify real market opportunities.

In the final section of the report, information related to the pharmaceutical excipients ‘Strategic Recommendation’ is included to provide report companies with insights required while entering a specific segment or a country to strengthen their revenue footprints in the pharmaceutical excipients market and to differentiate themselves. Key categories of providers covered in the report are pharmaceutical excipients manufacturers. Detailed company profiles have been primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a key market segment in the pharmaceutical excipients value chain and the potential players with respect to the same. Report audiences can gain segment-specific vendor insights to identify and evaluate key competitors based on the in-depth assessment of their capabilities and success in the pharmaceutical excipients marketplace.

Detailed profiles of the providers also include company-specific long-term and short-term strategies, key offerings, and recent developments in the pharmaceutical excipients market. Key competitors in the market, covered in terms of manufacturers, include BASF SE, Evonik Industries AG, Innophos Holdings Inc., The Lubrizol Corporation, The Dow Chemical Company, Wacker Chemie AG and Ashland Inc.

Key Segments Covered

By Source of Origin
Plant-based excipients
Animal-based excipients
Mineral-based excipients
Synthetic excipients

By Application Type
Oral Formulation
Topical Formulation
Parenteral Formulation
Others

By Functionality
Binders
Glidents
Diluents
Disintegrants
Others

By Region
North America
Latin America
Europe
Asia Pacific
Middle East & Africa

Key Companies
BASF SE,
Evonik Industries AG,
Innophos Holdings Inc.,
The Lubrizol Corporation,
The Dow Chemical Company,
Wacker Chemie AG and
Ashland Inc.

Table Of Contents

Global Market Study on Pharmaceutical Excipients: Increased Drug Demand in Emerging Asia Pacific Market to Fuel Demand Multi-Functional Excipients
1. Research Methodology

2. Assumptions and Acronyms Used

3. Executive Summary

4. Market Overview
4.1. Market Definition
4.1.1. Excipients by Function
4.1.2. Market Definition, By Chemistry (Source of Origin)
4.1.3. Market Definition, By Applications
4.1.4. Market Definition, By Functionality
4.2. Global Pharmaceutical Excipients Market Scenario and Forecast

5. Market Dynamics
5.1. Drivers
5.2. Restraints
5.3. Opportunity
5.4. Trends

6. Global Pharmaceutical Excipient Market Size and Forecast
6.1. Introduction
6.1.1. Y-o-Y Growth Projection
6.1.2. Absolute $ Opportunity

7. Global Pharmaceutical Excipients Market Dynamics, By Chemistry Type, 2015-2021
7.1. Introduction
7.1.1. Y-o-Y Growth Projection
7.1.2. Market Value Share and BPS Analysis By Chemistry Type
7.2. Plant-based
7.2.1. Y-o-Y Growth Projection
7.2.2. Absolute $ Opportunity
7.3. Animal Chemistry
7.3.1. Y-o-Y Growth Projection
7.3.2. Absolute $ Opportunity
7.4. Mineral
7.4.1. Y-o-Y Growth Projection
7.4.2. Absolute $ Opportunity
7.5. Synthetic
7.5.1. Y-o-Y Growth Projection
7.5.2. Absolute $ Opportunity
7.6. Global Pharmaceutical Excipients Market Attractiveness Analysis By Chemistry Type Segment
7.7. Global Pharmaceutical Excipient Market Trends By Chemistry Type

8. Global Pharmaceutical Excipients Market Dynamics, By Application Type, 2015-2021
8.1. Introduction
8.1.1. Y-o-Y Growth Projection
8.1.2. Market Value Share and BPS Analysis By Application Type
8.2. Oral Application
8.2.1. Y-o-Y Growth Projection
8.2.2. Absolute $ Opportunity
8.3. Topical Application
8.3.1. Y-o-Y Growth Projection
8.3.2. Absolute $ Opportunity
8.4. Parenteral Application
8.4.1. Y-o-Y Growth Projection
8.4.2. Absolute $ Opportunity
8.5. Other Application
8.5.1. Y-o-Y Growth Projection
8.5.2. Absolute $ Opportunity
8.6. Global Pharmaceutical Excipients Market Attractiveness Analysis By Application Type Segment
8.7. Global Pharmaceutical Excipient Market Trends By Dosage Formulation

9. Global Pharmaceutical Excipients Market Dynamics, By Functionality, 2015-2021
9.1. Introduction
9.1.1. Y-o-Y Growth Projection
9.1.2. Market Value Share and BPS Analysis By Functionality
9.2. Binders
9.2.1. Y-o-Y Growth Projection
9.2.2. Absolute $ Opportunity
9.3. Diluents
9.3.1. Y-o-Y Growth Projection
9.3.2. Absolute $ Opportunity
9.4. Glidants
9.4.1. Y-o-Y Growth Projection
9.4.2. Absolute $ Opportunity
9.5. Disintegrant
9.5.1. Y-o-Y Growth Projection
9.5.2. Absolute $ Opportunity
9.6. Others
9.6.1. Y-o-Y Growth Projection
9.6.2. Absolute $ Opportunity
9.7. Global Pharmaceutical Excipients Market Attractiveness Analysis By Functionality Type
9.8. Global Pharmaceutical Excipient Market Trends By Functionality

10. Global Pharmaceutical Excipients Market Dynamics, By Regions, 2015-2021
10.1. Introduction
10.1.1. Y-o-Y Growth Projection
10.1.2. Market Value Share and BPS Analysis By Region
10.2. North America
10.2.1. Y-o-Y Growth Projection
10.2.2. Absolute $ Opportunity
10.3. Latin America
10.3.1. Y-o-Y Growth Projection
10.3.2. Absolute $ Opportunity
10.4. Europe
10.4.1. Y-o-Y Growth Projection
10.4.2. Absolute $ Opportunity
10.5. Asia Pacific
10.5.1. Y-o-Y Growth Projection
10.5.2. Absolute $ Opportunity
10.6. MEA
10.6.1. Y-o-Y Growth Projection
10.6.2. Absolute $ Opportunity
10.7. Global Pharmaceutical Excipients Market Attractiveness Analysis By Region

11. North America Pharmaceutical Excipients Market Dynamics, 2015-2021
11.1. Introduction
11.1.1. Y-o-Y Growth Projection, By Country
11.1.2. Market Value Share and BPS Analysis By Country
11.2. U.S.
11.2.1. Y-o-Y Growth Projection
11.2.2. Absolute $ Opportunity
11.3. Canada
11.3.1. Y-o-Y Growth Projection
11.3.2. Absolute $ Opportunity
11.4. North America Pharmaceutical Excipients Market Attractiveness Analysis By Country
11.5. North America Pharmaceutical Excipients Market Value Forecast By Chemistry
11.6. North America Pharmaceutical Excipients Market Attractiveness Analysis By Chemistry
11.7. North America Pharmaceutical Excipients Market Value Forecast By Application Type
11.8. North America Pharmaceutical Excipients Market Attractiveness Analysis By Application
11.9. North America Pharmaceutical Excipients Market Value Forecast By Functionality
11.10. North America Pharmaceutical Excipients Market Attractiveness Analysis By Functionality
11.11. North America Pharmaceutical Excipients Market Trends
11.12. Drivers and Restraints Impact Analysis

12. Latin America Pharmaceutical Excipients Market Dynamics, 2015-2021
12.1. Introduction
12.1.1. Y-o-Y Growth Projection, By Country
12.1.2. Market Value Share and BPS Analysis By Country
12.2. Brazil
12.2.1. Y-o-Y Growth Projection
12.2.2. Absolute $ Opportunity
12.3. Mexico
12.3.1. Y-o-Y Growth Projection
12.3.2. Absolute $ Opportunity
12.4. Rest of Latin America
12.4.1. Y-o-Y Growth Projection
12.4.2. Absolute $ Opportunity
12.5. Latin America Pharmaceutical Excipients Market Attractiveness Analysis By Country
12.6. Latin America Pharmaceutical Excipients Market Value Forecast By Chemistry
12.7. Latin America Pharmaceutical Excipients Market Attractiveness Analysis By Chemistry
12.8. Latin America Pharmaceutical Excipients Market Value Forecast By Application Type
12.9. Latin America Pharmaceutical Excipients Market Attractiveness Analysis By Application
12.10. Latin America Pharmaceutical Excipients Market Value Forecast By Functionality
12.11. Latin America Pharmaceutical Excipients Market Attractiveness Analysis By Functionality
12.12. Latin America Pharmaceutical Excipients Market Trends
12.13. Drivers and Restraints Impact Analysis

13. Europe Pharmaceutical Excipients Market Dynamics, 2015-2021
13.1. Introduction
13.1.1. Y-o-Y Growth Projection, By Country
13.1.2. Market Value Share and BPS Analysis By Country
13.2. U.K.
13.2.1. Y-o-Y Growth Projection
13.2.2. Absolute $ Opportunity
13.3. Germany
13.3.1. Y-o-Y Growth Projection
13.3.2. Absolute $ Opportunity
13.4. Spain
13.4.1. Y-o-Y Growth Projection
13.4.2. Absolute $ Opportunity
13.5. Italy
13.5.1. Y-o-Y Growth Projection
13.5.2. Absolute $ Opportunity
13.6. France
13.6.1. Y-o-Y Growth Projection
13.6.2. Absolute $ Opportunity
13.7. Rest of Europe
13.7.1. Y-o-Y Growth Projection
13.7.2. Absolute $ Opportunity
13.8. Europe Pharmaceutical Excipients Market Attractiveness Analysis By Country
13.9. Europe Pharmaceutical Excipients Market Value Forecast By Chemistry
13.10. Europe Pharmaceutical Excipients Market Attractiveness Analysis By Chemistry
13.11. Europe Pharmaceutical Excipients Market Value Forecast By Application Type
13.12. Europe Pharmaceutical Excipients Market Attractiveness Analysis By Application
13.13. Europe Pharmaceutical Excipients Market Value Forecast By Functionality
13.14. Europe Pharmaceutical Excipients Market Attractiveness Analysis By Functionality
13.15. Europe Pharmaceutical Excipients Market Trends
13.16. Drivers and Restraints Impact Analysis

14. Asia Pacific Pharmaceutical Excipients Market Dynamics, 2015-2021
14.1. Introduction
14.1.1. Y-o-Y Growth Projection, By Country
14.1.2. Market Value Share and BPS Analysis By Country
14.2. Australia and New Zealand
14.2.1. Y-o-Y Growth Projection
14.2.2. Absolute $ Opportunity
14.3. Greater China
14.3.1. Y-o-Y Growth Projection
14.3.2. Absolute $ Opportunity
14.4. Japan
14.4.1. Y-o-Y Growth Projection
14.4.2. Absolute $ Opportunity
14.5. India
14.5.1. Y-o-Y Growth Projection
14.5.2. Absolute $ Opportunity
14.6. Rest of Asia Pacific
14.6.1. Y-o-Y Growth Projection
14.6.2. Absolute $ Opportunity
14.7. Asia Pacific Pharmaceutical Excipients Market Attractiveness Analysis By Country
14.8. Asia Pacific Pharmaceutical Excipients Market Value Forecast By Chemistry
14.9. Asia Pacific Pharmaceutical Excipients Market Attractiveness Analysis By Chemistry
14.10. Asia Pacific Pharmaceutical Excipients Market Value Forecast By Application Type
14.11. Asia Pacific Pharmaceutical Excipients Market Attractiveness Analysis By Application
14.12. Asia Pacific Pharmaceutical Excipients Market Value Forecast By Functionality
14.13. Asia Pacific Pharmaceutical Excipients Market Attractiveness Analysis By Functionality
14.14. Asia Pacific Pharmaceutical Excipients Market Trends
14.15. Drivers and Restraints Impact Analysis

15. MEA Pharmaceutical Excipients Market Dynamics, 2015-2021
15.1. Introduction
15.1.1. Y-o-Y Growth Projection, By Country
15.1.2. Market Value Share and BPS Analysis By Country
15.2. GCC Countries
15.2.1. Y-o-Y Growth Projection
15.2.2. Absolute $ Opportunity
15.3. South Africa
15.3.1. Y-o-Y Growth Projection
15.3.2. Absolute $ Opportunity
15.4. Rest of MEA
15.4.1. Y-o-Y Growth Projection
15.4.2. Absolute $ Opportunity
15.5. MEA Pharmaceutical Excipients Market Attractiveness Analysis By Country
15.6. MEA Pharmaceutical Excipients Market Value Forecast By Chemistry
15.7. MEA Pharmaceutical Excipients Market Attractiveness Analysis By Chemistry
15.8. MEA Pharmaceutical Excipients Market Value Forecast By Application Type
15.9. MEA Pharmaceutical Excipients Market Attractiveness Analysis By Application
15.10. MEA Pharmaceutical Excipients Market Value Forecast By Functionality
15.11. MEA Pharmaceutical Excipients Market Attractiveness Analysis By Functionality
15.12. MEA Pharmaceutical Excipients Market Trends
15.13. Drivers and Restraints Impact Analysis

16. Company Profiles and Competitive Landscape
16.1. Competitive Landscape
16.2. Company Profiles
16.2.1. BASF SE
16.2.2. Evonik Industries AG
16.2.3. Innophos Holdings Inc.
16.2.4. The Lubrizol Corporation
16.2.5. The Dow Chemical Company
16.2.6. Wacker Chemie AG
16.2.7. Ashland Inc.

17. Strategic Insights
17.1. Market Entry - Key Considerations
17.2. Sourcing of Supplies
17.3. Vendor Management and Risk Assessment
17.4. Sample Industry Verbatim
17.5. Regulations U.S.
17.6. Key Recommendations

18. Global Pharmaceutical Excipients Market Forecast, 2015-2025
18.1. Introduction
18.1.1. Y-o-Y Growth Projection
18.1.2. Absolute $ Opportunity
18.2. Parent Market Overview
18.2.1. Introduction
18.2.1.1. Y-o-Y Growth Projection
18.2.1.2. Absolute $ Opportunity
18.3. Global Pharmaceutical Excipients Market Trends
18.4. Global Pharmaceutical Excipients Market Snapshot (2014)

19. Global Pharmaceutical Excipients Market Analysis, By Chemistry Type
19.1. Introduction
19.1.1. Y-o-Y Growth Comparison, By Chemistry Type
19.1.2. BPS Analysis, By Chemistry Type
19.2. Market Value and Volume Forecast, By Chemistry Type
19.2.1. Plant
19.2.1.1. Absolute $ Opportunity
19.2.1.2. Market Value Forecast
19.2.2. Animals
19.2.2.1. Absolute $ Opportunity
19.2.2.2. Market Value Forecast
19.2.3. Minerals
19.2.3.1. Absolute $ Opportunity
19.2.3.2. Market Value Forecast
19.2.4. Synthetic
19.2.4.1. Absolute $ Opportunity
19.2.4.2. Market Value Forecast
19.3. Global Pharmaceutical Excipients Market Attractiveness Analysis, By Chemistry Type Segment

20. Global Pharmaceutical Excipients Market Analysis, By Application
20.1. Introduction
20.1.1. Y-o-Y Growth Comparison, By Application
20.1.2. BPS Analysis, By Application
20.2. Market Value and Volume Forecast, By Application
20.2.1. Oral
20.2.1.1. Absolute $ Opportunity
20.2.1.2. Market Value Forecast
20.2.2. Topical
20.2.2.1. Absolute $ Opportunity
20.2.2.2. Market Value Forecast
20.2.3. Parenteral
20.2.3.1. Absolute $ Opportunity
20.2.3.2. Market Value Forecast
20.2.4. Others
20.2.4.1. Absolute $ Opportunity
20.2.4.2. Market Value Forecast
20.3. Global Pharmaceutical Excipients Market Attractiveness Analysis, By Application Segment

21. Global Pharmaceutical Excipients Market Analysis, By Functionality
21.1. Introduction
21.1.1. Y-o-Y Growth Comparison, By Functionality
21.1.2. BPS Analysis, By Functionality
21.2. Market Value and Volume Forecast, By Functionality
21.2.1. Latin America
21.2.2. Latin America
21.2.3. Europe
21.2.4. Asia Pacific
21.2.5. MEA
21.3. Global Pharmaceutical Excipients Market Attractiveness Analysis, By Functionality

22. Latin America Global Pharmaceutical Excipients Market Analysis
22.1. Introduction
22.1.1. Y-o-Y Growth Comparison
22.1.1.1. By Country
22.1.1.2. By Chemistry Type
22.1.1.3. By Application Type
22.1.1.4. By Functionality
22.1.2. BPS Analysis
22.1.2.1. By Country
22.1.2.2. By Chemistry Type
22.1.2.3. By Application Type
22.1.2.4. By Functionality
22.2. Latin America Market Forecast, By Country
22.2.1. U.S.
22.2.1.1. Absolute $ Opportunity
22.2.1.2. Market Value Forecast
22.2.2. Canada
22.2.2.1. Absolute $ Opportunity
22.2.2.2. Market Value Forecast
22.3. Latin America Market Forecast, By Chemistry Type
22.3.1. Plants
22.3.1.1. Absolute $ Opportunity
22.3.1.2. Market Value Forecast
22.3.2. Animal
22.3.2.1. Absolute $ Opportunity
22.3.2.2. Market Value Forecast
22.3.3. Mineral
22.3.3.1. Absolute $ Opportunity
22.3.3.2. Market Value Forecast
22.3.4. Synthetic
22.3.4.1. Absolute $ Opportunity
22.3.4.2. Market Value Forecast
22.4. Latin America Market Forecast, By Application
22.4.1. Oral
22.4.1.1. Absolute $ Opportunity
22.4.1.2. Market Value Forecast
22.4.2. Topical
22.4.2.1. Absolute $ Opportunity
22.4.2.2. Market Value Forecast
22.4.3. Parenteral
22.4.3.1. Absolute $ Opportunity
22.4.3.2. Market Value Forecast
22.4.4. Others
22.4.4.1. Absolute $ Opportunity
22.4.4.2. Market Value Forecast
22.5. Latin America Market Trends and Impact Analysis of Drivers and Restraints

23. Latin America Global Pharmaceutical Excipients Market Analysis
23.1. Introduction
23.1.1. Y-o-Y Growth Comparison
23.1.1.1. By Country
23.1.1.2. By Chemistry Type
23.1.1.3. By Application Type
23.1.1.4. By Functionality
23.1.2. BPS Analysis
23.1.2.1. By Country
23.1.2.2. By Chemistry Type
23.1.2.3. By Application Type
23.1.2.4. By Functionality
23.2. Latin America Market Forecast, By Country
23.2.1. Mexico
23.2.1.1. Absolute $ Opportunity
23.2.1.2. Market Value Forecast
23.2.2. Brazil
23.2.2.1. Absolute $ Opportunity
23.2.2.2. Market Value Forecast
23.2.3. Rest of Latin America
23.2.3.1. Absolute $ Opportunity
23.2.3.2. Market Value Forecast
23.3. Latin America Market Forecast, By Chemistry Type
23.3.1. Plants
23.3.1.1. Absolute $ Opportunity
23.3.1.2. Market Value Forecast
23.3.2. Animals
23.3.2.1. Absolute $ Opportunity
23.3.2.2. Market Value Forecast
23.3.3. Synthetic
23.3.3.1. Absolute $ Opportunity
23.3.3.2. Market Value Forecast
23.4. Latin America Market Forecast, By Functionality
23.4.1. Hospitals
23.4.1.1. Absolute $ Opportunity
23.4.1.2. Market Value Forecast
23.4.2. Ambulatory Surgical Centres
23.4.2.1. Absolute $ Opportunity
23.4.2.2. Market Value Forecast
23.4.3. Diagnostics Centres
23.4.3.1. Absolute $ Opportunity
23.4.3.2. Market Value Forecast
23.5. Latin America Market Trends and Impact Analysis of Drivers and Restraints

24. Western Europe Global Pharmaceutical Excipients Market Analysis
24.1. Introduction
24.1.1. Y-o-Y Growth Comparison
24.1.1.1. By Country
24.1.1.2. By Chemistry Type
24.1.1.3. By Functionality
24.1.2. BPS Analysis
24.1.2.1. By Country
24.1.2.2. By Chemistry Type
24.1.2.3. By Functionality
24.2. Western Europe Market Forecast, By Country
24.2.1. Germany
24.2.1.1. Absolute $ Opportunity
24.2.1.2. Market Value Forecast
24.2.2. France
24.2.2.1. Absolute $ Opportunity
24.2.2.2. Market Value Forecast
24.2.3. U.K.
24.2.3.1. Absolute $ Opportunity
24.2.3.2. Market Value Forecast
24.2.4. Spain
24.2.4.1. Absolute $ Opportunity
24.2.4.2. Market Value Forecast
24.2.5. Italy
24.2.5.1. Absolute $ Opportunity
24.2.5.2. Market Value Forecast
24.2.6. Rest of Western Europe
24.2.6.1. Absolute $ Opportunity
24.2.6.2. Market Value Forecast
24.3. Western Europe Market Forecast, By Chemistry Type
24.3.1. Plants
24.3.1.1. Absolute $ Opportunity
24.3.1.2. Market Value Forecast
24.3.2. Animals
24.3.2.1. Absolute $ Opportunity
24.3.2.2. Market Value Forecast
24.3.3. Synthetic
24.3.3.1. Absolute $ Opportunity
24.3.3.2. Market Value Forecast
24.4. Western Europe Market Forecast, By Functionality
24.4.1. Hospitals
24.4.1.1. Absolute $ Opportunity
24.4.1.2. Market Value Forecast
24.4.2. Ambulatory Surgical Centres
24.4.2.1. Absolute $ Opportunity
24.4.2.2. Market Value Forecast
24.4.3. Diagnostics Centres
24.4.3.1. Absolute $ Opportunity
24.4.3.2. Market Value Forecast
24.5. Western Europe Market Trends and Impact Analysis of Drivers and Restraints

25. Eastern Europe Global Pharmaceutical Excipients Market Analysis
25.1. Introduction
25.1.1. Y-o-Y Growth Comparison
25.1.1.1. By Country
25.1.1.2. By Chemistry Type
25.1.1.3. By Functionality
25.1.2. BPS Analysis
25.1.2.1. By Country
25.1.2.2. By Chemistry Type
25.1.2.3. By Functionality
25.2. Eastern Europe Market Forecast, By Country
25.2.1. Russia
25.2.1.1. Absolute $ Opportunity
25.2.1.2. Market Value Forecast
25.2.2. Poland
25.2.2.1. Absolute $ Opportunity
25.2.2.2. Market Value Forecast
25.2.3. Rest of Eastern Europe
25.2.3.1. Absolute $ Opportunity
25.2.3.2. Market Value Forecast
25.3. Eastern Europe Market Forecast, By Chemistry Type
25.3.1. Plants
25.3.1.1. Absolute $ Opportunity
25.3.1.2. Market Value Forecast
25.3.2. Animals
25.3.2.1. Absolute $ Opportunity
25.3.2.2. Market Value Forecast
25.3.3. Synthetic
25.3.3.1. Absolute $ Opportunity
25.3.3.2. Market Value Forecast
25.4. Eastern Europe Market Forecast, By Functionality
25.4.1. Hospitals
25.4.1.1. Absolute $ Opportunity
25.4.1.2. Market Value Forecast
25.4.2. Ambulatory Surgical Centres
25.4.2.1. Absolute $ Opportunity
25.4.2.2. Market Value Forecast
25.4.3. Diagnostics Centres
25.4.3.1. Absolute $ Opportunity
25.4.3.2. Market Value Forecast
25.5. Eastern Europe Market Trends and Impact Analysis of Drivers and Restraints

26. APEJ Global Pharmaceutical Excipients Market
26.1. Introduction
26.1.1. Y-o-Y Growth Comparison
26.1.1.1. By Country
26.1.1.2. By Chemistry Type
26.1.1.3. By Functionality
26.1.2. BPS Analysis
26.1.2.1. By Country
26.1.2.2. By Chemistry Type
26.1.2.3. By Functionality
26.2. APEJ Market Forecast, By Country
26.2.1. Greater China
26.2.1.1. Absolute $ Opportunity
26.2.1.2. Market Value Forecast
26.2.2. India
26.2.2.1. Absolute $ Opportunity
26.2.2.2. Market Value Forecast
26.2.3. Australia and New Zealand
26.2.3.1. Absolute $ Opportunity
26.2.3.2. Market Value Forecast
26.2.4. Rest of APEJ
26.2.4.1. Absolute $ Opportunity
26.2.4.2. Market Value Forecast
26.3. APEJ Market Forecast, By Chemistry Type
26.3.1. Plants
26.3.1.1. Absolute $ Opportunity
26.3.1.2. Market Value Forecast
26.3.2. Animals
26.3.2.1. Absolute $ Opportunity
26.3.2.2. Market Value Forecast
26.3.3. Synthetic
26.3.3.1. Absolute $ Opportunity
26.3.3.2. Market Value Forecast
26.4. APEJ Market Forecast, By Functionality
26.4.1. Hospitals
26.4.1.1. Absolute $ Opportunity
26.4.1.2. Market Value Forecast
26.4.2. Ambulatory Surgical Centres
26.4.2.1. Absolute $ Opportunity
26.4.2.2. Market Value Forecast
26.4.3. Diagnostics Centres
26.4.3.1. Absolute $ Opportunity
26.4.3.2. Market Value Forecast
26.5. APEJ Market Trends and Impact Analysis of Drivers and Restraints

27. Japan Global Pharmaceutical Excipients Market
27.1. Introduction
27.1.1. Y-o-Y Growth Comparison
27.1.1.1. By Chemistry Type
27.1.1.2. By Functionality
27.1.2. BPS Analysis
27.1.2.1. By Chemistry Type
27.1.2.2. By Functionality
27.2. Japan Market Forecast, By Chemistry Type
27.2.1. Plants
27.2.1.1. Absolute $ Opportunity
27.2.1.2. Market Value Forecast
27.2.2. Animals
27.2.2.1. Absolute $ Opportunity
27.2.2.2. Market Value Forecast
27.2.3. Synthetic
27.2.3.1. Absolute $ Opportunity
27.2.3.2. Market Value Forecast
27.3. Japan Market Forecast, By Functionality
27.3.1. Hospitals
27.3.1.1. Absolute $ Opportunity
27.3.1.2. Market Value Forecast
27.3.2. Ambulatory Surgical Centres
27.3.2.1. Absolute $ Opportunity
27.3.2.2. Market Value Forecast
27.3.3. Diagnostics Centres
27.3.3.1. Absolute $ Opportunity
27.3.3.2. Market Value Forecast
27.4. Japan Market Trends and Impact Analysis of Drivers and Restraints

28. MEA Global Pharmaceutical Excipients Market
28.1. Introduction
28.1.1. Y-o-Y Growth Comparison
28.1.1.1. By Country
28.1.1.2. By Chemistry Type
28.1.1.3. By Functionality
28.1.2. BPS Analysis
28.1.2.1. By Country
28.1.2.2. By Chemistry Type
28.1.2.3. By Functionality
28.2. MEA Market Forecast, By Country
28.2.1. GCC
28.2.1.1. Absolute $ Opportunity
28.2.1.2. Market Value Forecast
28.2.2. South Africa
28.2.2.1. Absolute $ Opportunity
28.2.2.2. Market Value Forecast
28.2.3. Rest of MEA
28.2.3.1. Absolute $ Opportunity
28.2.3.2. Market Value Forecast
28.3. MEA Market Forecast, By Chemistry Type
28.3.1. Plants
28.3.1.1. Absolute $ Opportunity
28.3.1.2. Market Value Forecast
28.3.2. Animals
28.3.2.1. Absolute $ Opportunity
28.3.2.2. Market Value Forecast
28.3.3. Synthetic
28.3.3.1. Absolute $ Opportunity
28.3.3.2. Market Value Forecast
28.4. MEA Market Forecast, By Functionality
28.4.1. Hospitals
28.4.1.1. Absolute $ Opportunity
28.4.1.2. Market Value Forecast
28.4.2. Ambulatory Surgical Centres
28.4.2.1. Absolute $ Opportunity
28.4.2.2. Market Value Forecast
28.4.3. Diagnostics Centres
28.4.3.1. Absolute $ Opportunity
28.4.3.2. Market Value Forecast
28.5. MEA Market Trends and Impact Analysis of Drivers and Restraints

29. Competitive Landscape
29.1. Competition Dashboard
29.2. Company Share Analysis
29.3. BASF SE
29.4. Evonik Industries AG
29.5. Innophos Holdings Inc.
29.6. The Lubrizol Corporation
29.7. The Dow Chemical Company
29.8. Wacker Chemie AG
29.9. Ashland Inc.

30. Strategic Insights
30.1. Market Entry - Key Considerations

List of Tables

Table 1: North America Pharmaceutical Excipients Market Value (US$) Forecast By Chemistry Type Segment, 2015-2021
Table 2: North America Pharmaceutical Excipients Market Value (US$) Forecast By Application Type Segment, 2015-2021
Table 3: North America Pharmaceutical Excipients Market Value (US$) Forecast By Functionality segment, 2015-2021
Table 4: Latin America Pharmaceutical Excipients Market Value (US$ Mn) Forecast By Chemistry Type Segment, 2015-2021
Table 5: Latin America Pharmaceutical Excipients Market Value (US$ Mn) Forecast By Application Type Segment, 2015-2021
Table 6: Latin America Pharmaceutical Excipients Market Value (US$ Mn) Forecast, By Functionality Segment, 2015-2021
Table 7: Europe Pharmaceutical Excipients Market Value (US$ Mn) Forecast By Chemistry Type Segment, 2015-2021
Table 8: Europe Pharmaceutical Excipients Market Value (US$ Mn) Forecast By Application Type Segment, 2015-2021
Table 9: Europe Pharmaceutical Excipients Market Value (US$ Mn) Forecast By Functionality Segment, 2015-2021
Table 10: Asia Pacific Pharmaceutical Excipients Market Value (US$ Mn) Forecast By Chemistry Type Segment, 2015-2021
Table 11: Asia Pacific Pharmaceutical Excipients Market Value (US$ Mn) Forecast By Application Type Segment, 2015-2021
Table 12: Asia Pacific Pharmaceutical Excipients Market Value (US$ Mn) Forecast By Functionality Segment, 2015-2021
Table 13: MEA Pharmaceutical Excipients Market Value (US$ Mn) Forecast By Chemistry Type Segment, 2015-2021
Table 14: MEA Pharmaceutical Excipients Market Value (US$ Mn) Forecast By Application Type Segment, 2015-2021
Table 15: MEA Pharmaceutical Excipients Market Value (US$ Mn) Forecast By Functionality Segment, 2015-2021

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorde ...

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025 Summary Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis typically affecting the large joints, especially ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.